You did everything the same. Same meals. Same movement. Same routine. Somewhere around 40, it stopped working. The weight crept on. The energy disappeared. Sleep fell apart.
Then Wegovy came up in conversation.
If you're a woman in perimenopause taking or considering Wegovy, there are specific things worth knowing — because perimenopause changes the equation significantly.
Why the rules changed in your 40s
Declining oestrogen reduces insulin sensitivity. Progesterone fluctuations affect appetite, water retention, and sleep. Cortisol tends to run higher, driving abdominal fat storage. Muscle mass declines as oestrogen's protective effect wanes.
Research shows nearly 80% of women experience weight gain during the menopausal transition. This isn't about willpower.
80%
Of women experience weight gain during the menopausal transition — driven by hormonal shifts, not discipline failures
20%
Of women aged 50–64 reported current or past GLP-1 use (RAND 2025) — the highest of any age group
1.2–1.6g
Grams of protein per kg of body weight needed daily — even more critical in perimenopause than for younger women
Wegovy's effectiveness for perimenopausal women
Wegovy (semaglutide 2.4mg) is specifically approved for weight management and appears to work as effectively for perimenopausal and postmenopausal women as for younger women. RAND 2025 data showed women aged 50–64 had the highest GLP-1 use overall, with 20% reporting current or past use.
At the full 2.4mg dose, appetite suppression is significant. This is both the benefit and the risk for women over 40.
“A prescription is one piece. The foundations are what determine whether the results hold through the hormonal transition you're navigating.”
Why the risks hit harder in perimenopause
01
Muscle loss is compounded
Wegovy's potent appetite suppression makes it harder to eat enough protein. You're already losing muscle from oestrogen decline. Inadequate protein plus suppressed appetite plus no resistance training is a recipe for accelerated muscle loss that can take years to reverse.
How to prevent muscle loss on Wegovy02
Bone density
Rapid weight loss plus declining oestrogen equals increased osteoporosis risk. Progressive resistance training and weight-bearing exercise are protective — not just for muscle, but for bone mineral density.
03
Sleep disruption
Night sweats, insomnia, and early waking are hallmarks of perimenopause. Poor sleep increases ghrelin, decreases leptin, increases insulin resistance, and elevates cortisol. If sleep isn't addressed, the medication is fighting an uphill battle.
04
GI symptoms
Perimenopausal GI sensitivity plus Wegovy's gastric slowing can amplify nausea and bloating. Starting at 0.25mg and escalating slowly is especially important — don't rush the titration.
What to prioritise
Protein at every meal
1.2–1.6g per kg daily. Every meal protein-forward. When appetite is suppressed, what you eat matters more than how much.
Resistance training
Two to three times per week. Progressive, challenging. Protects both muscle and bone density — both under threat in perimenopause.
Sleep as a clinical priority
Not an afterthought. Poor sleep undermines insulin sensitivity, hunger hormones, and cortisol — everything the medication is trying to improve.
DEXA scans
Monitor body composition, not just weight. Know whether you're losing fat or muscle. Course-correct early if needed.
A prescription is one piece. The foundations are what determine whether the results hold through the hormonal transition you're navigating.
Related reading
On Wegovy in perimenopause and want proper support?
I work specifically with women in midlife navigating the intersection of hormonal change and metabolic health — including GLP-1 medications. Book a free 30-minute consultation to talk through where you are.
Book a free consultation
